Lifevantage (LFVN) Reports Q3 EPS of $0.20, Revenues Miss; Offers FY21 EPS Mid-Point Guidance Below Consensus

Go back to Lifevantage (LFVN) Reports Q3 EPS of $0.20, Revenues Miss; Offers FY21 EPS Mid-Point Guidance Below Consensus

Lifevantage Corporation (LFVN) PT Lowered to $9.50 at Lane Research Following Earnings

April 30, 2021 12:34 PM EDT

Lane Research analyst Douglas Lane lowered the price target on Lifevantage Corporation (NASDAQ: LFVN) to $9.50 (from $10.90) while maintaining a Hold rating.

The analyst commented, "F3Q (Mar) sales and operating income were below expectations, each showing year over year declines. While... More